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Research
Although air pollution has been recognized 
as a risk factor for cardiovascular morbid-
ity and mortality (Brook et al. 2004), its 
mechanism of action remains largely unclear. 
Inflammation has been proposed as a pos-
sible mechanism, and this possibility is sup-
ported by experimental models (Donaldson 
et al. 2003; Niwa et al. 2008; Vogel et al. 
2005) and population studies (Rückerl et al. 
2006, 2007; Schwartz 2001). A key player 
in modulating the inflammatory response is 
interleukin-6 (IL-6), a pleiotropic cytokine 
shown to be associated with increased risk 
of cardiovascular morbidity and mortality 
(Rattazzi et al. 2003).
Levels of IL-6 in plasma may be affected 
by specific genetic variations of both the 
gene encoding IL-6 (IL6; GenBank acces-
sion number M18403) (Bennermo et al. 
2004; Burzotta et al. 2001) and genes 
encoding the fibrinogen protein [α-chain 
(FGA), β-chain (FGB), and γ-chain (FGG); 
GenBank accession numbers NM_000508, 
NM_005141, and NM_021870, respectively] 
(Mannila et al. 2007; National Center for 
Biotechnology Information 2009). Because 
IL-6 principally stimulates fibrinogen produc-
tion (Dalmon et al. 1993), a possible explana-
tion for increased IL-6 levels in association 
with certain fibrinogen gene polymorphisms 
is a positive feedback mechanism where 
fibrinogen products (fibrin) increase IL-6 
production in monocytes and macrophages 
(Ritchie et al. 1982; Robson et al. 1994; 
Szaba and Smiley 2002).
Several studies have shown expression 
of the IL6 gene to be induced by air pollu-
tion (Quay et al. 1998; Vogel et al. 2005; 
Watterson et al. 2007), but no studies have 
examined induction of fibrinogen genes or 
examined variants of the IL6 gene and how 
they may possibly lead to differences in indi-
vidual susceptibility to air pollution. In pre-
vious analyses from this study population, 
genetic polymorphisms of fibrinogen have 
been associated with increased fibrinogen 
plasma levels (Jacquemin et al. 2008) and 
modified the fibrinogen response to ambient 
particulate matter (PM) (Peters et al. 2009). 
In light of a positive feedback mechanism 
of fibrinogen levels on IL-6 levels, poly-
morphisms of fibrinogen may potentially 
affect IL-6 levels differently through dif-
ferences in transcription rate of fibrinogen. 
Indeed, combinations of polymorphisms in 
the IL6 and fibrinogen genes may interact to 
further increase IL-6 levels.
Myocardial infarction (MI) survivors 
have a compromised long-term prognosis, 
making relative risk reduction particularly 
advan  tageous. We hypothesized that the 
moderate effect of air pollution seen on 
inflammatory markers in previous stud-
ies is stronger in MI survivors with specific 
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Ba c k g r o u n d: Evidence suggests that cardiovascular effects of air pollution are mediated by 
  inflammation and that air pollution can induce genetic expression of the interleukin-6 gene (IL6).
oBjectives: We investigated whether IL6 and fibrinogen gene variants can affect plasma IL-6 
responses to air pollution in patients with cardiovascular disease.
Me t h o d s : We repeatedly determined plasma IL-6 in 955 myocardial infarction survivors from 
six European cities (n = 5,539). We conducted city-specific analyses using additive mixed models 
adjusting for patient characteristics, time trend, and weather to assess the impact of air pollutants 
on plasma IL-6. We pooled city-specific estimates using meta-analysis methodology. We selected 
three IL6 single-nucleotide polymorphisms (SNPs) and one SNP each from the fibrinogen α-chain 
gene (FGA) and β-chain gene (FGB) for gene–environment analyses.
re s u l t s: We found the most consistent modifications for variants in IL6 rs2069832 and FBG 
rs1800790 after exposure to carbon monoxide (CO; 24-hr average; p-values for interaction, 0.034 
and 0.019, respectively). Nitrogen dioxide effects were consistently modified, but p-values for 
interaction were larger (0.09 and 0.19, respectively). The strongest effects were seen 6–11 hr after 
exposure, when, for example, the overall effect of a 2.2% increase in IL-6 per 0.64 mg/m3 CO was 
modified to a 10% (95% confidence interval, 4.6–16%) increase in IL-6 (p-value for interaction = 
0.002) for minor homozygotes of FGB rs1800790.
co n c l u s i o n s: The effect of gaseous traffic-related air pollution on inflammation may be stronger 
in genetic subpopulations with ischemic heart disease. This information could offer an opportunity 
to identify postinfarction patients who would benefit more than others from a cleaner environment 
and antiinflammatory treatment.
key w o r d s : air pollution, fibrinogen, gene–environment interaction, interleukin-6, myocardial 
infarction survivors, polymorphisms. Environ Health Perspect 117:1373–1379 (2009).  doi:10.1289/
ehp.0800370 available via http://dx.doi.org/ [Online 6 April 2009]Ljungman et al.
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variants of inflammatory genes such as IL6 
and the fibrinogen genes. We aimed to assess 
the influence of polymorphisms of the IL6, 
FGA, and FGB genes on the IL-6 response to 
air pollution and to explore the influence of 
gene–gene interactions on this effect. 
We present here results of a meta-analysis 
of six independent studies whose data were 
collected by a common protocol and that 
were designed to look at gene–air pollution 
interactions (Peters et al. 2007)
Materials and Methods
Patients. IL-6 concentrations were assessed 
in the AIRGENE study, a multicenter lon-
gitudinal study of MI survivors from six 
European cities: Athens, Greece; Augsburg, 
Germany; Barcelona, Spain; Helsinki, Finland; 
Rome, Italy; Stockholm, Sweden (Peters et al. 
2007). Subjects between 35 and 80 years of 
age who had experienced an MI between 4 
months and 6 years before start of the study 
were recruited through population-based MI 
registries (KORA MI Registry Augsburg, and 
registries in Barcelona and Stockholm) or from 
administrative databases of hospital admissions 
(Athens, Helsinki, and Rome). Patients with 
MI or interventional procedures < 3 months 
before the beginning of the study or with 
chronic recurring inflammatory diseases such as 
Crohn’s disease were excluded. MI was defined 
based on the European Society of Cardiology/
American College of Cardiology Committee 
criteria (Anonymous 2000). Study protocols 
were approved by local ethics committees, and 
written consent was obtained from all patients 
before inclusion in the study.
Patients were invited to participate in six 
to eight clinical visits between May 2003 and 
July 2004. The visits were scheduled every 
4–6 weeks, on the same weekday and at the 
same time of the day to minimize the impact 
of weekly and circadian variation in biological 
processes and air pollution levels. The average 
number of visits per patient was 5.8, result-
ing in 5,813 plasma samples. The subjects 
recruited were predominantly middle-age men 
who had survived one MI for > 2 years on 
average (Table 1).
Field study. The fieldwork was based on 
standard operating procedures developed by 
the AIRGENE study group. At a baseline 
clinical visit, a single blood sample for DNA 
analysis was collected and stored at –80°C 
until shipment on dry ice for DNA isolation 
at the laboratory at the Helmholtz Zentrum 
München—German Research Center for 
Environmental Health in Neuherberg, 
Germany. Patients were also characterized at 
baseline with respect to comorbidities, smok-
ing history, environmental tobacco exposures, 
socioeconomic status, regular exercise, and 
alcohol and medication intake. Measurements 
of blood pressure, body mass index (BMI), 
total cholesterol, high-density lipoprotein 
(HDL) cholesterol, glycosylated hemoglobin 
A1c (HbA1c), and N-terminal proB-type natri-
uretic peptide (NT-proBNP) were   performed.
At each repeated clinical visit, including 
baseline, a short questionnaire was admin-
istered regarding smoking behavior, time of 
last meal, and a 7-day recall of medication 
intake. In addition, a blood sample was col-
lected for IL-6 assessment according to previ-
ously described procedures (Peters et al. 2007). 
For quality assurance purposes, 102 randomly 
selected IL-6 duplicate samples from all cen-
ters except Athens were analyzed, showing an 
average coefficient of variation of 13.8% (from 
3.2% in Augsburg to 23.4% in Stockholm).
Air pollution. Data on hourly means of 
carbon monoxide (CO), nitrogen dioxide 
(NO2), PM with an aerodynamic diameter 
≤ 10 µm (PM10) or ≤ 2.5 µm (PM2.5), particle 
number concentration (PNC), air tempera-
ture, and relative humidity were collected for 
each city (Rückerl et al. 2007) and aggregated 
to 6- and 24-hr running means on the basis of 
standard procedures (Katsouyanni et al. 1995). 
Inhalable (PM10) and thoracic (PM2.5) par-
ticles were strongly correlated (overall r across 
cities for consecutive 24-hr means = 0.81), 
and local combustion-related pollutants were 
strongly correlated (CO and NO2, overall r = 
0.68; and both also to PNC, overall r = 0.67 
and 0.74, respectively). We also saw this over-
all pattern in the single cities, with the excep-
tion of Athens and Stockholm, which showed 
less correlation between CO and PNC.
Table 1. Data on patient characteristics, IL-6 measurements, and air pollution concentrations in the AIRGENE study.
Variable Helsinki Stockholm Augsburg Rome Barcelona Athens Total
No. 182 193 187 132 160 101 955
Sex (% male) 69.8 71.0 81.8 87.1 84.4 86.1 79.0
Age (years)a 64.4 (45–78) 64.0 (38–76) 61.9 (39–76) 62.5 (39–79) 62.1 (37–81) 54.5 (38–75) 62.2 (37–81)
BMI (kg/m2)a 28.8 (19.1–48.9) 27.6 (17.5–43.3) 28.9 (19.1–48.4) 27.7 (19.0–39.4) 28.8 (19.4–43.5) 28.8 (20.9–46.4) 28.4 (17.5–48.9)
HDL/total cholesterola 0.3 (0.1–0.6) 0.3 (0.1–0.6) 0.3 (0.1–0.5) 0.2 (0.1–0.5) 0.3 (0.1–0.5) 0.2 (0.1–0.6) 0.3 (0.1–0.6)
HbA1c (%)a 5.9 (4.7–9.2) 5.1 (3.8–9.9) 5.6 (4.7–9.8) 5.4 (2.8–8.7) 5.1 (3.8–9.8) 5.9 (3.7–10.5) 5.5 (2.8–10.5)
NT-proBNP (pg/mL)a 392.9 (10.8–3,799) 330.4 (14.0–3,348) 482.5 (12.5–9,308) 405.0 (19.1–6,174) 380.6 (11.3–7,057) 314.9 (11.0–4,855) 389.1 (10.8–9,308)
Current smokers (%) 1.7 0.5 0 9.1 13.8 38.6 8.1
Pack-years (cigarettes only)a 9.2 (0–65.0) 12.2 (0–73.8) 15.2 (0–205.2) 22.0 (0–171.8) 28.4 (0–193.2) 35.6 (0–174.0) 18.8 (0–205.2)
Time between last MI and 2.7 (0.6–5.8) 2.3 (0.6–3.9) 2.1 (0.5–3.4) 2.7 (0.4–6.0) 2.2 (0.4–5.9) 2.4 (0.5–5.0) 2.4 (0.4–6.0)
  study start (years)a
First MI (%) 81.9  86.5 88.2  87.1 85.6 81.2 85.3
Self-reported historyb
  Arrhythmia (%) 1.7 1.8 1.8 1.8 1.9 1.8 1.8
  Chronic bronchitis (%) 1.8 1.8 1.9 1.9 2.0 2.0 1.9
  Hypertension (%) 1.5 1.5 1.5 1.4 1.5 1.4 1.5
Blood samples (n) 1,081 1,146 1,067 728 1,059 458 5,539
IL-6 (pg/mL)c 3.1 (0.9–19.7) 2.6 (0.5–24.4) 2.5 (0.6–11.8) 3.0 (1.0–61.4) 3.5 (0.8–28.5) 3.0 (0.8–22.4) 3.0 (0.5–61.4)
Air pollution measurement 5 Sep 2003 to 30 Aug 2003 to 14 May 2003 to 20 Sep 2003 to 30 Aug 2003 to 8 Sep 2003 to
  (study period)d   2 Jun 2004   24 June 2004   24 Feb 2004   15 Jul 2004   16 Jun 2004   30 Jul 2004
  CO (mg/m3) 0.31 (0.26–0.34) 0.29 (0.25–0.34) 0.58 (0.43–0.66) 1.40 (1.02–1.66) 0.59 (0.45–0.70) 1.48 (0.95–1.68) 0.78 (0.56–0.90)
  NO2 (µg/m3) 28.6 (20.5–34.6) 18.4 (12.7–22.9) 40.0 (32.7–46.5) 67.0 (56.7–76.3) 50.5 (39.3–60.4) 50.2 (42.0–59.0) 42.4 (34.0–49.9)
  PM2.5 (µg/m3) 8.2 (4.7–10.4) 8.8 (6.0–10.3) 17.4 (12.2–21.2) 24.6 (14.0–30.7) 24.2 (13.5–29.7) 23.0 (14.9–29.1) 17.7 (10.9–21.9)
  PM10 (µg/m3) 17.1 (10.5–20.7) 17.8 (11.0–21.7) 33.1 (22.0–42.7) 42.1 (30.6–49.9) 40.7 (25.1–49.2) 38.5 (27.1–46.4) 31.6 (21.1–38.4)
  PNC (per cm3) 8,534 (5,834–10,519) 9,748 (7,247–11,625) 11,876 (7,085–14,440) 35,450 (21,094–46,963) 18,133 (10,492–24,278) 20,590 (11,872–26,913) 17,388 (10,604–22,456)
Pearson correlation
  CO
  NO2 0.76 0.56 0.53 0.75 0.70 0.55 0.69
  PM2.5 0.38 0.53 0.61 0.70 0.26 0.45 0.55
  PM10 0.25 0.30 0.60 0.71 0.30 0.17 0.47
  PNC 0.60 0.23 0.77 0.87 0.64 0.25 0.67
aMean (range). bEver diagnosed by a physician. cMean (range) of the subject-specific means based on three to eight repeated measurements. dMean (25th–75th percentile) for 
  consecutive 24-hr means across study period.Air pollution, genes, and IL-6
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Genotyping. We extracted DNA from 
EDTA (ethylenediaminetetraacetic acid)–
anticoagulated blood using a salting out 
procedure. We selected 10 single-nucleotide 
polymorphisms (SNPs) for IL6 and 21 SNPs 
for FGA, FGB, and FGG and genotyped them 
as described previously (Peters et al. 2007). 
Genotyping success rates ranged between 
97.9% for IL6 rs2069832 and 99.8% for 
FGB rs1800790.
SNP selection. We selected IL6 SNPs that 
showed an association with IL-6 levels in our 
sample (p-value < 0.05) and were in Hardy-
Weinberg equilibrium for gene–environment 
analyses (Ljungman et al. 2008). Five SNPs 
met this criterion, but IL6 rs2069832 and 
rs1800795 were in very high linkage disequi-
librium (LD) (r2 = 0.99), as were rs1554606 
and rs2069845 (r2 = 0.99). Therefore, one of 
each pair (rs2069832 and rs1554606) was cho-
sen for further gene–environment interaction 
analyses. IL6 rs2069840 was, however, in weak 
LD (r2 = 0.31 to 0.35) with the other selected 
SNPs and might have independent effects. 
Associations have been seen between IL-6 lev-
els and fibrinogen levels (Mannila et al. 2004), 
and previous analyses in our study population 
(Jacquemin et al. 2008) have shown evidence 
of modification of the effect of fibrinogen 
polymorphisms on fibrinogen levels by levels 
of IL-6. Consequently, we selected one SNP 
each from the genes coding the α-chain (FGA, 
rs2070011) and β-chain (FGB, rs1800790) 
of fibrinogen, which were both associated 
with fibrinogen levels in the previous study 
(Jacquemin et al. 2008), based on these results.
Of the 1003 study participants, we 
restricted all further analyses to 955 (95%) for 
whom complete information on the five SNPs 
was available.
Statistical analysis. We estimated the effect 
of the SNPs on IL-6 using linear mixed effects 
models with random subject-specific inter-
cepts, adjusting linearly for the variables age, 
BMI, pack-years of cigarette smoking, HDL 
cholesterol, systolic blood pressure, alcohol 
intake, and logarithm of NT-proBNP and for 
the categorical variables city, HbA1c, num-
ber of earlier MIs, history of heart failure or 
diabetes, and symptoms of phlegm. SNP gen-
otypes were coded as an ordinal variable by the 
number of copies of the minor allele (0, 1, 2; 
denoted 1 1, 1 2, and 2 2 in tables and figures) 
as described in Ljungman et al. (2008).
For detailed information on model selec-
tion procedures, see Rückerl et al. (2007). We 
estimated the overall effects of air pollutants 
on IL-6 in city-specific additive mixed mod-
els [see Supplemental Material, Table 1 (doi: 
10.1289/ehp.0800370.S1 via http://dx.doi.
org/)], adjusting for the above-described 
patient characteristics, time trend, and the 
weather parameters air temperature and rela-
tive humidity to accommodate the different 
characteristics and meteorologic conditions 
across Europe, as previously reported (Rückerl 
et al. 2007). We tested the robustness of the 
model to exclusion of all time-invariant vari-
ables in sensitivity analyses.
Gene–environment interactions were esti-
mated for each SNP by including in these 
models the main effect of the SNP (addi-
tive genetic model), the main effect of the 
air pollution effect, and the interaction term 
between air pollution and SNP. We deter-
mined the a priori exposure window for all 
gene–environment interaction analyses to be 
the average exposure during the 24 hr imme-
diately preceding blood withdrawal based 
on results from previous analyses (Rückerl 
et al. 2007) and the short half-life of IL-6. 
Secondary analyses were performed for other 
time windows of exposure as well as for 
gene–gene combinations of polymorphisms 
showing effect modification. We explored 
consistency of patterns of association in city-
specific analyses. In assessing the contribu-
tions of the different exposure windows to the 
interaction effect, we also performed analyses 
for the subjects carrying at least one risk allele 
using distributed lags, thus allowing for inde-
pendence of effects for each time window of 
exposure in a common model.
Effect estimates by genotypes are pre-
sented together with 95% confidence intervals 
(CIs). Because the study of gene–environment 
interactions was of an exploratory nature, 
we did not attempt to correct for multiple 
comparisons for these analyses. Estimates are 
presented for an increase of the pollutants by 
a one interquartile increase in pollutant expo-
sure range and expressed as a relative change of 
the overall geometric mean in IL-6. We tested 
the assumption of an additive genetic effect by 
using an indicator variable for the heterozygote 
genotype in the model. For overall results, 
we pooled city-specific estimates using meta-
analysis methodology (van Houwelingen et al. 
2002). Heterogeneity of effect estimates was 
assessed with a chi-square test with 5 degrees 
of freedom. If the p-value was < 0.1, random 
effect models were applied for combining 
effect estimates.
Results
Mean IL-6 ranged from 2.5 pg/mL in Augsburg 
to 3.5 pg/mL in Barcelona (Table 1). The con-
secutive 24-hr mean levels of CO ranged from 
0.29 mg/m3 in Stockholm to 1.48 mg/m3 in 
Athens. The within-interquartile difference 
ranged from 0.08 in Helsinki to 0.73 in Athens.
Less than 5% of the subjects were 
homozygotes for the minor allele of FGB 
rs1800790, whereas 9–19% of subjects were 
homozygotes for minor allele of the IL6 and 
FGA polymorphisms (Table 2). Genotype 
frequencies differed among the cities for all 
SNPs (chi-square test, p < 0.03), displaying a 
north–south gradient, with the minor alleles 
of IL6 rs2069832 and IL6 rs2069845 having 
higher frequencies in the northern cities and 
the minor alleles of IL6 rs2069840 having 
higher frequencies in the southern cities. The 
fibrinogen SNPs did not show such a pattern 
(data not shown).
Overall effect of genotype on IL-6   levels. 
Table 2 shows the associations of SNPs with 
an increased plasma level of IL-6 in this 
data set. The minor alleles of IL6 rs2069832 
and IL6 rs2069845 and the major allele of 
IL6 rs2069840 were significantly associated 
with an increased plasma level (at p < 0.05) 
(Ljungman et al. 2008). The minor allele of 
FGA rs2070011 showed nonsignificant asso-
ciation to increased plasma levels of IL-6, 
whereas FGB rs1800790 polymorphism 
showed no clear association to plasma IL-6. 
Table 2. SNPs and SNP–IL-6 association: characteristics of the analyzed SNPs of IL6, FGB, and FGA and their association with plasma IL-6 concentrations.
Alleles Genotype frequency [% (n)] Difference in IL-6a level ll
Functional Major (1)/ Minor allele  Homozygote of Heterozygote Homozygote of [% overall mean: effect of
SNP region Minor (2) frequency [% (n)] major allele (1 1) (1 2) minor allele (2 2) two alleles (2 2 vs. 1 1)]
IL6
  rs2069832 Intron G/A 40 (768) 36 (696) 47 (892) 17 (322) 13.4 (3.7 to 24.0)
  rs2069840 Intron C/G 31 (602) 46 (884) 45 (850) 9 (176) –9.6 (–17.2 to –1.3)
  rs2069845 Intron A/G 43 (820) 33 (632) 48 (918) 19 (360) 14.6 (4.7 to 25.4)
FGA
  rs2070011 Promoter C/T 39 (744) 39 (738) 45 (858) 16 (314) 8.1 (–0.5 to 17.5)
FGB
  rs1800790 Promoter G/A 20 (386)  63 (1,210) 33 (628) 4 (72) –5.6 (–14.7 to 4.4)
aEffect estimates and 95% CIs from linear mixed model analysis with log IL-6 as outcome, with a random effect for subject to account for repeated measurements, using an additive 
genetic model for the genotypes, and adjusted for age, city, glycosylated hemoglobin, number of earlier MIs, earlier diagnosed heart failure or diabetes, symptoms of phlegm, BMI, 
pack-years of cigarette smoking, HDL cholesterol, systolic blood pressure, alcohol intake, and log NT-proBNP.Ljungman et al.
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We found no evidence of deviation from the 
additive model for these SNPs (p-value for 
heterozygote indicator variable > 0.05).
Overall effects of air pollution on IL-6 
  levels. Elevated concentrations of CO averaged 
during the 0–24 hr preceding blood sampling 
were not significantly associated with increased 
plasma IL-6 levels (Table 3), but elevated con-
centrations during 6–11 hr intervals preced-
ing sampling were associated (2.2% change of 
overall mean IL-6; 95% CI, 0.3–4.2%). For 
other pollutants, NO2 levels averaged over the 
0–24 hr preceding blood sampling showed 
associations with an increase in plasma IL-6 
(Table 3), and PNC levels showed significant 
associations for both 6–11 hr and 12–17 hr 
exposure windows preceding sampling [1.8% 
change (95% CI, 0.2–3.5%) and 2.6% change 
(95% CI, 0.8–4.5%), respectively].
Genotype modification of IL-6 response 
(24-hr exposure windows). Subjects with the 
homozygous major allele genotypes for all 
three IL6 polymorphisms showed larger IL-6 
responses to increased CO, but only for for 
IL6 rs2069832 was a similar genetic inter-
action seen with increased NO2 (Table 4).
Subjects with the homozygote minor 
allele genotype of FGB rs1800790 showed 
both a larger and clearer effect modification 
for the IL-6 response to increased CO com-
pared with the IL6 SNPs. The overall effect 
of a 0.8% increase in IL-6 per 0.34 mg/m3 
increase of CO in the preceding 0–24 hr 
seemed to be confined to individuals carry-
ing the minor allele of FGB rs1800790. In 
the 4% of the study sample that were homo-
zygous with this allele, the corresponding CO 
effect on IL-6 was a 4.5% increase. We saw 
similar magnitudes of effect modification for 
NO2, but the effect modification pattern was 
not statistically significant. The FGA SNP 
did not modify the response to air pollution. 
These results were robust to sensitivity analysis 
excluding all time-invariant variables from the 
final model and only maintaining time trend 
and meteorology (data not shown).
For PM pollutants, we found a simi-
lar pattern of effect modification of FGB 
rs1800790 for increased levels of PM2.5 and 
PM10 during the preceding 0–24 hr, but with 
less precision of effect for PM10 (Figure 1). 
For ultrafine particles measured by PNC and 
for IL6 rs2069832, the pattern was less clear.
When we classified different combinations 
of the IL6 rs2069832 and FGB rs1800790 
genotypes according to number of risk 
alleles into low, intermediate, and high risk 
(Figure 2A), we found significant modifica-
tion of the IL-6 response to an increase in the 
preceding 0–24 hr average of CO as well as 
both NO2 and PM2.5 (Figure 2B). Subjects 
with ≥ three high-risk alleles from both SNPs 
(154 subjects) had the largest IL-6 response.
Genotype modification of IL-6 response 
(6-hr exposure windows). Analyses of 6-hr 
exposure windows during the 24 hr immedi-
ately preceding blood sampling showed the 
clearest effect modification of the IL-6 response 
to CO within the three preceding 6-hr win-
dows (Figure 3). We found greatest effect 
modification for FGB rs1800790 for increased 
CO during the 6–11 hr preceding sampling. 
The overall effect of a 2.2% increase in IL-6 
per 0.64 mg/m3 increase of CO in this time 
window seemed again to be confined to 
individuals carrying the minor allele of FGB 
rs1800790, with a 10% (95% CI, 4.6–16%) 
increase in homo  zygotes (4% of study sample). 
Table 3. Effect of 24-hr interquartile range increase in air pollution on IL-6 plasma levels. 
Air pollutant response Interquartile Change of IL-6a (% of overall mean
without genetic covariate range increase per interquartile range increase)  p-Value
CO 0.34 mg/m3 0.8 (–0.5 to 2.1) 0.22
NO2 15.9 µg/m3 1.7 (0.2 to 3.4) 0.03
PNC 11,852/cm3 1.9 (–0.2 to 4.0) 0.07
PM2.5 11.0 µg/m3 0.6 (–0.8 to 2.0) 0.40
PM10 17.4 µg/m3 0.0 (–1.3 to 1.3) 1.0
aInverse-weighted sum of city-specific estimates and 95% CIs from linear regression using log IL-6 concentrations as 
outcome, with a random effect for subject, using the 24-hr average of air pollutants fitted to the time of IL-6 measure-
ment and adjusting for age, city, BMI, log NT-proBNP, HDL cholesterol, systolic blood pressure, number of MIs, glyco-
sylated hemoglobin, pack-years of cigarette smoking, alcohol intake, history of arrhythmias, heart failure, bronchitis, 
season, apparent temperature, relative humidity, and hour of visit in city-specific models. 
Table 4. SNP–environment interactions: association between 24-hr average of CO or NO2 and plasma 
IL-6 levels by genotype for the analyzed polymorphisms in the genes IL6, FGA, and FGB.
Change of IL-6a (% of overall mean per
interquartile range increase of pollutant)
SNP Genotypeb CO NO2
IL6 rs2069832 1 1 2.0 (0.3 to 3.6) 3.1 (0.9 to 5.4)
1 2 –0.2 (–1.7 to 1.3) 1.2 (–0.5 to 3.0)
2 2 –2.0 (–4.7 to 0.8) –0.5 (–3.5 to 2.5)
p-Value 0.03 0.09
IL6 rs2069840 1 1 2.0 (0.3, 3.8) 1.8 (–0. 4 to 4.0)
1 2 0.4 (–0.9, 1.7) 1.7 (0.0 to 3.4)
2 2 –1.2 (–3.4, 1.1) 1.7 (–1.5 to 4.9)
p-Value 0.04 0.93
IL6 rs2069845 1 1 1.9 (0.2 to 3.5) 2.8 (0.5 to 5.1)
1 2 –0.1 (–1.5 to 1.4) 1.3 (–0.4 to3.1)
2 2 –1.6 (–4.3 to 1.2) 0.2 (–2.6 to 3.2)
p-Value 0.31 0.26
FGA rs2070011 1 1 1.0 (–0.7 to 2.7) 2.1 (–0.1 to 4.3)
1 2 0.7 (0.6 to 2.0) 1.6 (–0.1 to 3.3)
2 2 0.4 (–1.9 to 2.7) 1.1 (–1.8 to 4.1)
p-Value 0.64 0.64
FGB rs1800790 1 1 –0.2 (–1.8 to 1.3) 1.0 (–0.9 to 2.9)
1 2 2.1 (0.4 to 3.8) 2.8 (0.6 to 5.0)
2 2 4.5 (1.1 to 8.0) 4.4 (0.1 to 8.9)
p-Value 0.02 0.19
aInverse-variance weighted sum of city-specific estimates and 95% CIs from linear regression using IL-6 concentrations as 
outcome and an additive genetic model for the genotype, with a random effect by subject, using the 24-hr average of CO or 
NO2 fitting to the time of IL-6 measurement, including a genotype–CO interaction adjusted for age, city, BMI, log NT-proBNP, 
HDL cholesterol, systolic blood pressure, number of MIs, glycosylated hemoglobin, pack-years of cigarette smoking, alcohol 
intake, history of arrhythmias, heart failure, bronchitis, season, apparent temperature, relative humidity, and hour of visit in 
city-specific models. Interquartile range increase: CO, 0.34 mg/m3; NO2, 15.9 µg/m3. b1, major allele; 2, minor allele. 
Figure 1. Modification by IL6 rs2069832 (A) and FGB rs1800790 (B) genotypes of IL-6 response to increased 
24-hr average ambient CO, NO2, ultrafine PM (PNC), and PM2.5 immediately preceding blood withdrawal (1, 
major allele; 2, minor allele). Error bars indicate 95% CIs; p-values are for significance of the inter  action term. 
Interquartile ranges: CO, 34.0 mg/m3; NO2, 15.9 µg/m3; PNC, 11,852/cm3; PM2.5, 11.0 µg/m3; PM10, 17.4 µg/m3. 
*Heterogeneity of the city-specific effect estimates with a p-value < 0.1.
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In homozygotes for the major allele of IL6 
rs2069832 (36% of the study sample), the cor-
responding increase was 3.6% (95% CI, 1.0–
6.2%). Differences in the NO2 (Figure 3) and 
PM2.5 (data not shown) effects across genetic 
subgroups for different 6-hr exposure windows 
were similar but weaker. The distributed lag 
analyses restricted to subjects with at least one 
minor allele of FGB rs1800790 (GA or AA, 
37% of study sample) or one major allele of 
IL6 2069832 (GA or AA, 83% of study sam-
ple) for 6-hr and 24-hr time windows showed 
associations with increased IL-6 for increases 
in CO for the 0–5 hr and 6–11 hr preceding 
sampling [see Supplemental Material, Figure 1 
(doi: 10.1289/ehp.0800370.S1)]. The IL-6 
increase seen in minor allele holders of FGB 
rs1800790 for 0–23 hr exposure of CO seemed 
to be mainly driven by exposure in the 6–11 hr 
time window. We found a similar but weaker 
pattern for 0–23 hr exposure in major allele 
holders of IL6 rs2069832.
City-specific modification of IL-6 response to 
CO and NO2. In a comparison of city-specific 
analyses for IL6 rs2069832 [see Supplemental 
Material, Figure 2 (doi: 10.1289/ehp.0800370.
S1)], modification of the IL-6 response to pre-
ceding 0–24 hr average of increased CO and 
NO2 showed consistency between the pol-
lutants, with the clearest effect modification 
seen in Helsinki, Barcelona, and Athens. For 
FGB rs1800790 [see Supplemental Material, 
Figure 3 (doi: 10.1289/ehp.0800370.S1)], 
we found the strongest effect modification in 
Athens and Augsburg, and the effects were con-
sistent for both pollutants except in Stockholm. 
Although we found variation across cities 
because of reduced power in the city-specific 
analyses, we found no significant heterogeneity 
of city-  specific effects (p-value > 0.1).
Discussion
We found evidence of gene–environment 
interaction where the SNPs IL6 rs2069832 
and FGB rs1800790 modified the effects of 
air pollution on IL-6 levels in MI survivors. 
All pollutants showed similar patterns of effect, 
but results were most apparent for CO. The 
influence of CO on IL-6 levels was strongest in 
subjects with the major allele of IL6 rs2069832 
and the minor allele of FGB rs1800790, and 
the combination of these two genetic variants, 
present in 16% of subjects, resulted in a sig-
nificant gene–gene–environment interaction, 
potentially indicating a higher risk for health 
effects from air pollution in these patients 
with ischemic heart disease. We found similar 
magnitudes of effect modification with respect 
to air pollution for IL6 rs2069840 and IL6 
rs2069845, but we found no effect modifica-
tion for FGA rs2070011.
We found small effects of air pollution 
on IL-6 levels in the overall population. The 
groups defined by the minor allele of FGB 
rs1800790, and to a lesser extent by the major 
allele of IL6 rs2069832, seem to be the driving 
force between the associations seen, suggesting 
a restriction of the effect of air pollution to 
groups of MI survivors of specific genotypes.
NO2 was the pollutant with the most con-
vincing effects on IL-6 levels with respect to 
the a priori specified time window of exposure 
(0–24 hr) when considering the overall popu-
lation, regardless of genotype. Modification 
of air pollution effects by SNPs was, however, 
clearest for CO, although the other pollutants 
in general followed a similar pattern. CO has 
been proposed as a probable culprit to cardio-
vascular effects of air pollution (Dales 2004; 
McGrath 2000) in addition to PM. In this 
study we did not have sufficient power to more 
specifically identify the most important air pol-
lution component or source, and we acknowl-
edge that we studied a mixture of correlated 
pollutants. Ambient CO levels measured using 
fixed monitors have been shown to correlate 
better to personal exposure to PM rather than 
to personal exposure to CO (Sarnat et al. 
2005; Schwartz et al. 2007), so although sensi-
tivity analyses adjusting for the level of PM2.5 
in the models showed support for an indepen-
dent effect of CO (data not shown), we can 
not be sure of a specific CO effect. Secondary 
analyses showed that the interaction effect was 
clearest and strongest during the first 24 hr 
and particularly 6–11 hr preceding blood 
withdrawal, consistent with the short half-life 
of IL-6. The early effect was further supported 
by the distributed lag analyses of the subjects 
carrying the risk allele for IL6 rs2069832 and 
FGB rs1800790. Given the strong correlation 
of 6-hr exposure windows, it is probable that 
effects seen for exposure window 12–17 hr 
and possibly also 0–5 hr reflect this correla-
tion rather than independent effects of these 
exposure windows.
Figure 2. (A) Construction of gene–gene interaction variable based on relative change in plasma IL-6 in univari-
ate gene–environment interaction analysis of polymorphisms IL6 rs2069832 and FGB rs1800790. (B) Modification 
by gene–gene interaction of IL6 rs2069832 and FGB rs1800790 of IL-6 response to increased preceding ambient 
24-hr air pollutant averages. Error bars indicate 95% CIs, and p-values are for significance of the interaction 
term. Interquartile ranges: CO, 0.34 mg/m3; NO2, 15.9 µg/m3; PNC, 11,852/cm3; PM2.5, 11.0 µg/m3; PM10, 17.4 µg/m3. 
*Heterogeneity of the city-specific effect estimates with a p-value < 0.1. 
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Figure 3. Modification by IL6 rs2069832 and FGB rs1800790 genotypes of IL-6 response to increased ambi-
ent CO and NO2 in association with 6-hr exposure windows preceding blood sampling. Error bars indicate 
95% CIs, and p-values are for significance of the interaction term. Interquartile ranges for 6-hr means: CO, 
0.64 mg/m3; NO2, 11.5 µg/m3. 
*Heterogeneity of the city-specific effect estimates with a p-value < 0.1.
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Although FGB rs1800790 displayed an 
interaction effect with CO on IL-6 levels, 
we found no effect of the polymorphism on 
IL-6 in these patients when not taking air 
pollution into account. A previous study of 
the same population (Jacquemin et al. 2008) 
investigating the effect of fibrinogen poly-
morphisms on fibrinogen plasma levels found 
no inter  action effect with high levels of IL-6 
on fibrino  gen levels for this polymorphism, 
in contrast to FGA rs2070011. However, a 
follow-up study (Peters et al. 2009) showed 
that FGB rs1800790 modified the effect of a 
5-day average exposure to ambient PM on cir-
culating fibrinogen levels. The production of 
fibrinogen is stimulated by IL-6, but there is 
also evidence both in vivo (Szaba and Smiley 
2002) and in vitro (Robson et al. 1994) 
suggesting a positive feedback mechanism 
whereby fibrinogen products in turn stimulate 
IL-6 production and release from monocytes. 
Although this might suggest that the increased 
IL-6 levels seen in MI survivors with a minor 
allelic genotype of FGB rs1800790 are medi-
ated via increased fibrinogen levels, the effects 
on IL-6 levels occurred within 12 hr rather 
than after 5 days.
In this study, subjects with major alleles 
of IL6 rs2069832 and rs2069845 had lower 
IL-6 concentrations than did those with 
minor alleles, but they seemed to react more 
strongly to CO exposure than did minor 
allele holders. The reason for this pattern 
is unclear. Our previous study (Ljungman 
et al. 2008) revealed a tendency of a greater 
within-individual variability for major allele 
holders compared with minor allele holders. 
Taken together, this may indicate that major 
allele holders are more likely to respond with 
inflammation to stimuli such as air pollution 
but from a lower basal level of IL-6.
Air pollution has been associated in epide-
miologic studies with the onset of MIs in both 
previously healthy subjects and cardiac patients 
(Peters et al. 2001; Zanobetti and Schwartz 
2005). In addition, human experimental (Mills 
et al. 2007) and epidemiologic (Chuang et al. 
2008) studies have demonstrated an effect 
of air pollution on ST-segment changes in 
electrocardiograms indicating the triggering 
of acute ischemia. The gene–environment 
inter  action observed for these two SNPs in 
our study emphasizes that certain genetic sub-
groups of cardiac patients may react more 
strongly toward air pollution than do others. 
Similar genetic interaction with air pollutants 
has been seen in human and animal models 
for lung disease (Kleeberger 2003; London 
2007) and oxidative stress (Romieu et al. 2006; 
Schwartz et al. 2005). Although both the IL6 
and FGB genes are probable candidates affect-
ing the levels of the known cardio  vascular 
biomarker IL-6, the actual polymorphisms 
responsible for the observed effect modification 
may be other strongly correlated SNPs or com-
binations of SNPs. Indeed, in our population, 
IL6 rs2069832 has very high LD with IL6 
rs1800795, a functional SNP located in the 
promoter region. The reason for focusing on 
IL6 rs2069832 instead of IL6 rs1800795 was 
that the overall pooled effects of IL6 rs1800795 
on IL-6 levels showed slightly more hetero-
geneity across cities (Ljungman et al. 2008). 
To confirm the effects of the studied poly-
morphisms, functional analyses are required, 
and as our analyses suggest, the nature of pos-
sible gene–gene interaction effects in combina-
tions of SNPs possibly in different genes are of 
interest. In order to verify whether these data 
have any prognostic significance, follow-up of 
clinical ischemic events has to be performed.
Strengths and limitations. We conducted 
this study with data from six European cities, 
thereby providing six independent samples 
for testing gene–environment interactions. 
We focus here on genes that, applying a meta-
analytical approach across all cities, were asso-
ciated with gene–environment interactions.
The different cities, however, reflect not 
only a large variation of air pollution expo-
sure, which was desirable, but also other dif-
ferences possibly confounding our results. 
To control for this variation, we applied a 
two-step approach, starting with city-specific 
models and thereafter pooling the results and 
checking for evidence of heterogeneity. This 
test, however, suffers from low power, and 
the interaction effects showed some dispar-
ity across cities. We found clearer effects in 
Athens and Barcelona than in Helsinki or 
Stockholm. The southern European cities 
showed the highest mean levels and the great-
est variability in CO levels, whereas Stockholm 
and Helsinki showed very little variation and 
considerably lower mean levels. A sensitivity 
analysis excluding Athens did reduce the effect 
estimates for CO and increased the p-values 
of interaction, whereas results for NO2 and 
PM2.5 were essentially unchanged (data not 
shown). However, we present here a pooled 
analysis of six independently conducted stud-
ies based on a common protocol. Therefore, 
we regard the a priori planned analyses as 
valid, which include all cities, and especially 
those with the large exposure contrasts and 
therefore more power. By and large, the effects 
for CO were corroborated by those for NO2. 
The remaining differences might be attributed 
to possible differences in measurement error 
for the pollutants, as well as possible differ-
ences in how representative the fixed monitors 
are of urban background levels of the various 
pollutants. The low-risk allele showed point 
estimates below zero for the IL6 SNP and the 
combined SNPs in relation to increased CO, 
for which we have no clear explanation, but 
because we found no such tendency for the 
same genotypes in relation to NO2, this may 
be a chance finding. The temporal relation-
ship between exposure and effect within 12 hr 
generally fits the expected rise and fall of IL-6 
response in the bloodstream. A fair amount of 
measurement error was seen for IL-6, but we 
expect that this would not be associated with 
air pollution levels and therefore would lead 
to nondifferential misclassification, potentially 
attenuating our results.
We had expected a stronger main effect 
of CO and NO2 on IL-6 levels, but because 
air pollution is strongly linked to cardiovas-
cular mortality, survivors of MI—although 
at high absolute risk for future cardiovascular 
events—may be less susceptible to the effects 
of air pollution in a relative sense than the 
general population. Nevertheless, our results 
indicate that groups of these individuals iden-
tified by specific genotypes are at increased 
risk of a systemic inflammatory response 
in association with exposure to continuous 
ambient air pollution. Should this increase in 
IL-6 be confirmed to have prognostic impli-
cations, these individuals could be identified 
and protected with counseling such as avoid-
ance of traffic or going outdoors at periods of 
high risk, for example, within the first month 
after an MI or during highly polluted days. 
Furthermore, they might be helped by more 
rigorous medication.
Conclusion
The results support our hypothesis that the 
effect of air pollution on inflammation may 
be stronger in certain genetic subpopulations 
of cardiac patients. Polymorphisms in the IL6 
genes modified the IL-6 response when exposed 
to increased air pollution in the 6–11 hr period 
preceding sampling, consistent with biological 
expectation. The role of FGB rs1800790 also 
seemed important, although the rapid effect 
was unexpected. Combining these polymor-
phisms also showed a gene–gene interaction, 
possibly implicating that one-sixth of the pop-
ulation of MI survivors is at particular risk for 
effects of air pollution. Whether these differ-
ences in air-pollution–mediated inflammation 
have any prognostic importance remains to 
be clarified, as well as the possible role of these 
polymorphisms in air pollution effects on ear-
lier stages of cardiovascular morbidity.
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